1. Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020
- Author
-
Shah, Melisa M, Salvatore, Phillip P, Ford, Laura, Kamitani, Emiko, Whaley, Melissa J, Kaitlin, Mitchell, Currie, Dustin W, Morgan, Clint N, Segaloff, Hannah E, Lecher, Shirley, Somers, Tarah, Van Dyke, Miriam E, Bigouette, John Paul, Delaney, Augustina, DaSilva, Juliana, O’Hegarty, Michelle, Boyle-Estheimer, Lauren, Abdirizak, Fatima, Karpathy, Sandor E, Meece, Jennifer, Ivanic, Lynn, Goffard, Kimberly, Gieryn, Doug, Sterkel, Alana, Bateman, Allen, Kahrs, Juliana, Langolf, Kimberly, Zochert, Tara, Knight, Nancy W, Hsu, Christopher H, Kirking, Hannah L, and Tate, Jacqueline E
- Subjects
BinaxNOW ,AcademicSubjects/MED00290 ,COVID-19 Testing ,Wisconsin ,diagnostic performance ,SARS-CoV-2 ,antigen testing ,COVID-19 ,Humans ,Supplement Article ,Sensitivity and Specificity - Abstract
Repeating the BinaxNOW antigen test for SARS-CoV-2 by two groups of readers within 30 minutes resulted in high concordance (98.9%) in 2,110 encounters. BinaxNOW test sensitivity was 77.2% (258/334) compared to real-time reverse transcription-polymerase chain reaction. Same day antigen testing did not significantly improve test sensitivity while specificity remained high.
- Published
- 2021